The proposals of Fresenius Kabi Oncology for Rs 119 crore and Amneal Pharmaceuticals Company's for up to Rs 205 crore have been approved by the Foreign Investment Promotion Board (FIPB), a multi-department panel headed by Finance Secretary.
Indusind Bank's proposal seeking increase in foreign investment in the bank to 74% has also been cleared. The amount of fund flow would depend on when the actual transaction takes place in case of the bank.
Also Read
The bank, according to a release today, sought "a specific request to grant post-facto approval for increase in foreign holding from 68.51% to 72.07% on June 30, 2014".
These proposals were approved at the FIPB meeting held on September 16, it said.
Tamil Nadu-based Equitas Holdings Pvt Ltd, with the largest proposed investment in the lot, would bring foreign capital of Rs 325 crore.
The approval was sought by the company for downstream investment in its wholly owned subsidiaries by its existing and new foreign shareholders leading to increase in the foreign equity from 91.30% to 93.12%.
It is followed by Mumbai-based Tara India Fund envisaging investment of Rs 305.63 crore.
Under the defence sector, proposals of Bharti Shipyard Ltd and Solar Industries India will not lead to any fund flow.
Telecom player Verizon Communications India's proposal for increase in foreign equity participation by its foreign parent from 74% to 100% was approved entailing investment of Rs 2.32 crore.
Meanwhile, FIPB rejected 5 proposals including Sistema Shyam Teleservices Ltd.
SSTL sought permission to increase FDI up to 100% in the company and its downstream wholly owned subsidiary Shyam Internet Services Ltd, both engaged in the telecom sector, on account of conversion of redeemable preference shares into equity.
At the same time, 8 proposals including four from the pharma sector was rejected.
Proposals of BioMerieux India Pvt Ltd and Kusum Healthcare Pvt Ltd among pharma sectors were rejected.